Offer - Urjas Oil for just ₹ 1 X
Erlonat is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
The optimal dosage of Erlonat is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Erlonat can also lead to other problems, which have been listed below. Such side effects of Erlonat normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Erlonat has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Erlonat's effects on the liver, heart and kidney are discussed below in the Erlonat related warnings section.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease, Lung Disease must refrain from the use of Erlonat since this can cause severe adverse effects. Other contraindications of Erlonat have been discussed in the sections ahead.
Drug reaction of Erlonat with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Erlonat is not safe while driving, and is is not addictive in nature.
Erlonat is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Erlonat safe for pregnant women?
Erlonat may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlonat, and talk to their doctor, if they notice any discomfort.
Is the use of Erlonat safe during breastfeeding?
Breastfeeding women may feel side effects of Erlonat. If you see any side effects, stop taking Erlonat immediately and talk to your doctor. Take Erlonat again, only after your doctor's advice.
What is the effect of Erlonat on the Kidneys?
Erlonat does not damage the kidneys.
What is the effect of Erlonat on the Liver?
Erlonat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlonat on the Heart?
You can take Erlonat without any fear of damage to the heart.
Erlonat should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Erlonat unless your doctor advises you to do so -
Is this Erlonat habit forming or addictive?
Erlonat does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Erlonat. So it is best to avoid driving.
Is it safe?
Erlonat is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Erlonat for mental disorders.
Interaction between Food and Erlonat
Some foods when eaten with Erlonat can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlonat
It is difficult to say anything about the effect of Erlonat and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516